Strobel S, Morgan G, Simmonds A H, Levinsky R J
Department of Immunology, Institute of Child Health, London, United Kingdom.
Eur J Pediatr. 1989 Jan;148(4):312-4. doi: 10.1007/BF00444121.
Fatal graft versus host disease (GVHD) developed in a child with purine nucleoside phosphorylase (PNP) deficiency following an unirradiated platelet transfusion. IV treatment with an anti-T-cell monoclonal antibody (CD7) led to a transient improvement of his GVHD (Grade IV) but did not prevent the fatal outcome. This report emphasizes the need for blood products to be irradiated when cell mediated immunodeficiency is suspected, even in patients with residual immunocompetence.
一名嘌呤核苷磷酸化酶(PNP)缺乏的儿童在接受未辐照的血小板输注后发生了致命的移植物抗宿主病(GVHD)。静脉注射抗T细胞单克隆抗体(CD7)使他的GVHD(IV级)得到了短暂改善,但未能阻止致命结局。本报告强调,即使是具有残余免疫能力的患者,当怀疑存在细胞介导的免疫缺陷时,血液制品也需要进行辐照。